May 22, 2014

Chirag Patel — co-CEO, chairman and co-founder of Amneal Pharmaceuticals — will be honored with the Alumnus of Distinction Award at New Jersey City University’s American Dream Gala on June 5.

May 22, 2014

Prasco Labs on Thursday announced it has entered into a distribution and supply agreement with Recordati Rare Diseases for the rights to distribute ibuprofen lysine injection, the authorized generic version of NeoProfen (ibuprofen lysine).

May 22, 2014

Surescripts on Wednesday announced its service has routed more than 1 billion electronic prescriptions in 2013, representing a majority (58%) of all eligible prescriptions in the United States, sent by 73% of all office-based physicians.

May 21, 2014

According to a report published Monday by JAMA Pediatrics, cost-related barriers to care among children with asthma are concentrated among low-income families with higher cost-sharing levels.

May 16, 2014

Abbott announced a definitive agreement to acquire Latin American pharmaceutical company CFR Pharmaceuticals, more than doubling its Latin American branded generics pharmaceutical presence the company reported.

May 15, 2014

Greenstone announced the introduction of rifabutin capsules to its product line. The drug is the authorized generic version of Mycobutin.

May 15, 2014

Actavis has reached an agreement with Janssen Pharmaceuticals to continue supplying the authorized generic version of Janssen's Concerta (methylphenidate hydrochloride extended-release tablets), the company announced.

May 15, 2014

The Centers for Disease Control and Prevention on Wednesday released guidance advising practitioners to offer an HIV prevention pill to healthy individuals who are at high risk for an HIV infection, according to published reports.

May 15, 2014

The stampede of big-selling branded medicines that hurtled off the patent cliff in 2011 and 2012 has slowed to a relative trickle.

May 15, 2014

The Generic Pharmaceutical Association lobbied for greater access to generics at this week’s meeting of the chief negotiators of the Trans-Pacific Partnership in Ho Chi Minh City, Vietnam, the association announced Wednesday.

May 15, 2014

Call it the triumph of irrationality over self-interest. Healthcare experts and pharmacy leaders have been grappling with the challenge of patient nonadherence for decades.

May 15, 2014

A new report by Milliman released Thursday found that Silver plans with combined deductibles offered through the Health Insurance Exchanges may require patients to pay more than twice as much out of pocket for prescription medicines overall as they would under a typical employer plan.

May 15, 2014

Teva Pharmaceutical was denied in its suit to block approval of Mylan's and Sandoz' generic Copaxone, a multiple sclerosis, drug 10 days before the patent on the medication expires, according to a Bloomberg report published Thursday morning.

May 14, 2014

Actavis on Tuesday announced that it has received final approval from the Food and Drug Administration on its abbreviated new drug application for a generic version of Mallinckrodt's Exalgo (hydromorphone hydrochloride extended-release tablets 8 mg, 12 mg and 16 mg).

May 14, 2014

Actavis on Wednesday announced the proposed senior management team that will lead the specialty pharmaceutical company pending the successful close of the acquisition of Forest Labs, which is anticipated at mid-year.

May 14, 2014

The American College of Physicians, CECity and Pfizer on Wednesday announced a new initiative designed to increase adult immunization rates.

May 14, 2014

About half of all Americans reported taking one or more prescription drugs in the past 30 days during 2007-2010, and 1-in-10 took five or more, according to "Health, United States, 2013," the government’s annual, comprehensive report on the nation’s health that was released Wednesday.

May 14, 2014

Dr. Reddy's Labs has named Satish Reddy as chairman of the board. Reddy previously held the position of vice-chairman, managing director and COO. GV Prasad will continue to serve as CEO and provide leadership to the company in an executive capacity.

May 14, 2014

Dr. Reddy’s Laboratories on Tuesday posted $2.2 billion in annual sales for the fiscal year ended March 31, representing growth of 14%.

May 14, 2014

The Food and Drug Administration moved one step closer to establishing a biosimilar pathway with a new guidance document explaining how to use clinical pharmacology data to show similarity to a reference product, according to a report published by Regulatory Focus on Tuesday.

May 14, 2014

Mylan on Wednesday announced that it has launched olanzapine orally disintegrating tablets in 5-mg, 10-mg, 15-mg and 20-mg strengths. The drug is the generic version of Zyprexa Zydis tablets from Eli Lilly and Co.

May 14, 2014

The U.S. Department of Health and Human Services and the European Commission on Tuesday released the first progress report of the Transatlantic Taskforce on Antimicrobial Resistance.

May 13, 2014

KVK-Tech, a developer, manufacturer and marketer of specialty pharmaceuticals, announced the appointment of Joseph Lefebvre as VP business development, marketing and API sourcing.

May 13, 2014

Valeant Pharmaceuticals on Monday announced that certain of its subsidiaries have entered into settlement agreements with Actavis related to Actavis' generic versions of Tiazac XC.